Exelixis Inc (NAS:EXEL)
$ 20.82 -0.41 (-1.93%) Market Cap: 6.06 Bil Enterprise Value: 5.44 Bil PE Ratio: 32.38 PB Ratio: 2.89 GF Score: 92/100

Exelixis Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript

Jun 23, 2020 / 08:00PM GMT
Release Date Price: $23.9 (-1.12%)
George Farmer
BMO Capital Markets Equity Research - Analyst

Good afternoon, everyone. I'm George Farmer, BMO Biotechnology analyst. And with us atâ¦

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Can you hear me, George?

George Farmer
BMO Capital Markets Equity Research - Analyst

Yes, I can hear you, Mike. I'm in the process of introducing you. I'm introducing Mike Morrissey, the CEO of Exelixis for our final presentation of the day. Mike, I'm very happy that you're here to join us for a fireside chat. Really appreciate it. Thought maybe we could start off with some highlights from the COSMIC-021 trial that you've presented before. And maybe you can just kind of talk through about what's so exciting about the prostate and the lung cancer data cohorts in particular that you've seen to date.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

All right. Well, I can't hear you, guys. Can you hear me? Looks like you could hear me.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot